Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹ 21,808 millions in Q3FY23 showcasing a 3% rise on an YoY basis. In this quarter’s results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in Q3Y23.
Sun Pharmaceutical Q3FY23; 3% Growth in Profits
Tags: Pharmaceutical
Related Post
- Garden Reach Shipbuilders & Engineers Ltd Q2FY25; 10% rise in Profits
Garden Reach Shipbuilders & Engineers Ltd is a premier shipbuilding company in India under the…
-
GAIL (India) Ltd Q2FY25; 10% rise in Profits
Incorporated in 1984, GAIL, a Government of India undertaking, is an integrated natural gas company…
-
G R Infraprojects Ltd Q2FY25; 11% fall in Profits
Incorporated in the year 1995, G R Infraprojects Ltd is an integrated road Engineering, Procurement,…